S (SARS-CoV-1) |
21,492 |
25,259 |
3768 |
Spike Protein |
75.96% |
Facilitates viral entry and replication |
Induces apoptosis |
Chow et al., 2005, Jin and Zheng, 2009
|
S (SARS-CoV-2) |
21,563 |
25,384 |
3821 |
SARS3a (SARS-CoV-1) |
25,268 |
26,092 |
825 |
Hypothetical protein sars3a |
72.36% |
Antiviral interferon (IFN) response |
Induces Necrosis and apoptosis |
Kopecky-Bromberg et al., 2007, Law et al., 2005
|
ORF3a (SARS-CoV-2) |
25,393 |
26,220 |
827 |
SARS3b (SARS-CoV-1) |
25,689 |
26,153 |
465 |
Hypothetical protein sars3b |
– |
Antiviral interferon (IFN) response |
Induces both necrosis and apoptosis |
Kopecky-Bromberg et al., 2007 |
E (SARS-CoV-1) |
26,117 |
26,347 |
231 |
Envelope protein |
94.74% |
Controls viral replication, inhibition of anti-apoptotic protein |
Stress response and apoptosis pathways |
DeDiego et al., 2011, Yang et al., 2005
|
E (SARS-CoV-2) |
26,245 |
26,472 |
227 |
M (SARS-CoV-1) |
26,398 |
27,063 |
666 |
Matrix protein |
90.54% |
Defines the shape of the viral envelope, Allow the budding of virions |
Pro-apoptotic functions in host cells |
Neuman et al., 2011, Tsoi et al., 2014
|
M (SARS-CoV-2) |
26,523 |
27,191 |
668 |
SARS6 (SARS-CoV-1) |
26,913 |
27,265 |
353 |
Hypothetical protein sars6 |
68.85% |
Reduces production of INF |
Induces host cell apoptosis |
Neuman et al., 2011, Ye et al., 2008
|
ORF6 (SARS-CoV-2) |
27,202 |
27,387 |
185 |
SARS7a (SARS-CoV-1) |
27,273 |
27,641 |
369 |
Hypothetical protein sars7a |
85.25% |
Activates antiviral signaling |
Caspase-dependent apoptosis |
Tan et al., 2007 |
ORF7a (SARS-CoV-2) |
27,394 |
27,759 |
365 |
SARS7b (SARS-CoV-1) |
27,638 |
27,772 |
135 |
Hypothetical protein sars7b |
85.37% |
Pathogenesis of SARS-CoV infection |
Induces apoptosis |
Schaecher et al., 2007a |
ORF7b (SARS-CoV-2) |
27,756 |
27,887 |
131 |
SARS8a (SARS-CoV-1) |
27,779 |
27,898 |
120 |
Hypothetical protein sars8a |
– |
Viral replication |
Induces apoptosis |
Chen et al., 2007, Shi et al., 2019a
|
ORF8 (SARS-CoV-2) |
27,894 |
28,259 |
365 |
ORF8 protein |
– |
SARS8b (SARS-CoV-1) |
27,864 |
28,118 |
255 |
Hypothetical protein sars8b |
– |
Viral replication |
Activation of autophagy |
Chen et al., 2007, Shi et al., 2019a
|
N (SARS-CoV-1) |
28,120 |
29,388 |
1269 |
Nucleocapsid protein |
90.52% |
Actin reorganization |
Antagonist of IFN signaling |
Kopecky-Bromberg et al., 2007, Surjit et al., 2004
|
N (SARS-CoV-2) |
28,274 |
29,533 |
1259 |
SARS9b (SARS-CoV-1) |
28,130 |
28,426 |
297 |
Hypothetical protein sars9b |
– |
Suppress the innate immunity |
Induces apoptosis |
Shi et al., 2014b |
ORF10 (SARS-CoV-2) |
29,558 |
29,674 |
116 |
ORF10 protein |
– |
– |
– |
– |